Guggenheim Maintains Buy on Veracyte, Raises Price Target to $50

Benzinga · 5d ago
Guggenheim analyst Subbu Nambi maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $45 to $50.